News Releases

PDI Selects Dendrite's WebForce™ for its Select Access Sales Teams
Industry-leading Sales Effectiveness Solution Enables Sales Organization to Enhance Productivity

Saddle River, NJ and Bedminster, N.J. - April 13, 2005 - PDI, Inc. (NASDAQ: PDII), a diversified sales and marketing services provider to the biopharmaceutical and medical device and diagnostics industries, and Dendrite International, Inc. (NASDAQ: DRTE), a leading provider of sales, marketing, clinical, and compliance solutions for the pharmaceutical and life sciences industry, today announced that PDI, has entered into a three-year agreement to use Dendrite's WebForce solution, part of Dendrite's industry-leading sales effectiveness solutions suite, First Source Sales Applications™. WebForce will be used by PDI's Select Access™ sales teams, formerly PDI Shared Sales.

In addition, the agreement also calls for Dendrite to provide Select Access with a range of solutions, including ongoing implementation and help desk services, both critical components of the First Source Sales Support(SM) suite. These services enable a smooth transition as WebForce is adopted by the PDI Select Access sales teams.

With Dendrite's support solutions, the Select Access sales representatives will have rapid access to highly-trained support staff, offering customized support to enable maximum sales performance, while minimizing potential down time.

The decision to work with Dendrite represents a significant strategic initiative for Select Access, which will further enhance sales force effectiveness and productivity. PDI selected Dendrite because of their demonstrated track record of success, flexibility to customize its technology to a unique set of needs and speed of implementation.

WebForce, optimizes and coordinates promotional activities across sales teams, improves communications and streamlines new product launches. First Source Sales Applications is a comprehensive product suite that helps pharmaceutical and other life science companies manage all aspects of their sales force activities.

"Our Select Access sales solution is the only large-scale, shared selling model available. Our clients get 100 percent targeting flexibility at 40 percent below the average cost of a typical sales call. WebForce will increase the agility of our sales professionals in managing their territories and delivering sales results for our clients," said Chris Tama, Executive Vice President of PDI. "Given the importance of this decision, it is vital to have a partner with a deep understanding of our business and technology," he added. "PDI's decision to work with Dendrite reflects the fact that we understand the unique challenges of their business. We are keen to help them succeed and look forward to building a successful partnership with them," said Dendrite Senior Vice President Bob Parisi.

About Dendrite

Founded in 1986, Dendrite International (NASDAQ: DRTE) provides diversified sales, marketing, clinical and compliance solutions to the global life sciences and pharmaceutical industry. With clients in more than 50 countries, including the world top 20 pharmaceutical companies, Dendrite strives to be the first source for expert promotional and sales effectiveness solutions. For more information, please visit www.dendrite.com.

About PDI

PDI, Inc. (NASDAQ:PDII) is a diversified sales and marketing services provider to the biopharmaceutical and medical device and diagnostics industries. PDI’s comprehensive set of next-generation solutions is designed to increase its clients’ strategic flexibility and enhance their efficiency and profitability. Headquartered in Saddle River, NJ, PDI also has offices in Pennsylvania and Illinois.

PDI’s sales and marketing services include dedicated, shared, clinical and combination sales teams; marketing research and consulting; medical education and communications; talent recruitment; and integrated commercial solutions from pre-launch through patent-expiration. The company’s experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.

PDI’s commitment is to deliver innovative solutions, excellent execution and superior results to its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI continues to innovate today as a thought-starter for the outsourcing of sales and marketing services.

For more information, visit the Company’s website at www.pdi-inc.com.

About Select Access

Select Access, formerly PDI Shared Sales, a targeted sales solution for a diverse group of pharmaceutical products, leverages an existing infrastructure to maximize brand profitability. Rapid deployment and national coverage by approximately 350 experienced sales professionals in high prescribing territories increases speed to impact. Select Access is the only alternative sales force model that gives clients complete target audience control and flexibility and where the majority of sales calls are dedicated to a single product detail.

Select Access’ unmatched value is perfectly aligned to increase incremental revenue for established brands, OTC brands, and for specialty brands that could gain an additional revenue stream from a primary care presence.

For more information, visit the website at www.select-access.com.

Copyright © Select Access, a division of PDI, Inc. • Information Privacy Policy

About Select Access | Markets Served | Press & Media | Target Coverage Analysis | Contact Us | PDI, Inc.